Germline vs somatic: where a variant belongs

In one sentence

Germline variants can be passed through eggs or sperm, while somatic variants arise in other cell lineages.

The intuition

Imagine a book distributed to many rooms. A change in the original edition can appear across those rooms. A change made in one room's copy stays in that branch of copies. This helps distinguish a person's constitutional DNA from an acquired cell-lineage change. The analogy has limits: mosaicism can place a variant in only some tissues, and a new germline variant need not have come from a parent.

How it works

An inherited germline variant is generally present across many tissues. Germline variants can also arise anew in an egg, sperm or early development. Somatic changes arise outside that reproductive lineage. Cancer cells acquire somatic changes, but normal cells can acquire them too.

Finding a change in a tumor does not establish its origin. A matched-normal sample supplies non-tumor DNA from the same person for comparison. The same variant in tumor and suitable normal material may support constitutional origin. A tumor-only result may need a separate clinical hereditary test to resolve that question.

Blood is often convenient as the normal sample, but blood cells can have acquired mutations of their own. That is called clonal hematopoiesis. Low-level mosaicism, contamination and assay limits can also complicate interpretation. The laboratory's specimen choice and analysis rules matter.

Why it matters in cancer

The distinction changes the question being answered. Tumor profiling asks about the sampled cancer. Hereditary testing asks about inherited susceptibility and possible family implications. A biologically relevant tumor variant does not automatically establish a hereditary finding or satisfy an eligibility rule requiring a germline result.

Worked example

A fictional tumor test finds a repair-gene variant. The report cannot yet say whether it is inherited. An appropriate clinical normal-sample test then fails to find it within its validated detection scope. That supports a somatic interpretation under those conditions; it does not prove that every possible hereditary cause was excluded.

Now reverse the scenario: the variant is found in normal tissue. Its presence alone still does not establish that it is harmful. Origin and pathogenicity are separate labels.

Common confusions

Germline does not mean necessarily inherited from a parent.
Somatic does not mean cancer-specific; normal cell lineages acquire changes.
A negative tumor assay is not a comprehensive negative hereditary test.
Research matched-normal analysis is not automatically a clinical hereditary report.

How it is measured

Laboratories compare tumor and normal material or perform a dedicated hereditary assay. Reports differ in coverage, validation, detection limits and what they disclose. Preserve the actual signed classification and confirm ambiguous origins through the appropriate clinical workflow.

Sources and scope

Source check: October 9, 2026. General genetics teaching; expert and learner review remain pending.